Unknown

Dataset Information

0

Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1).

ABSTRACT: Myotonic dystrophy type 1 (DM1), the most common form of muscular dystrophy in adults, is an RNA-mediated disease. Dramatically expanded (CUG) repeats accumulate in nuclei and sequester RNA-binding proteins such as the splicing regulator MBNL1. We have employed resin-bound dynamic combinatorial chemistry (RBDCC) to identify the first examples of compounds able to inhibit MBNL1 binding to (CUG) repeat RNA. Screening an RBDCL with a theoretical diversity of 11 325 members yielded several molecules with significant selectivity for binding to (CUG) repeat RNA over other sequences. These compounds were also able to inhibit the interaction of GGG-(CUG)(109)-GGG RNA with MBNL1 in vitro, with K(i) values in the low micromolar range.

SUBMITTER: Gareiss PC 

PROVIDER: S-EPMC2645920 | biostudies-literature | 2008 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1).

Gareiss Peter C PC   Sobczak Krzysztof K   McNaughton Brian R BR   Palde Prakash B PB   Thornton Charles A CA   Miller Benjamin L BL  

Journal of the American Chemical Society 20081201 48

Myotonic dystrophy type 1 (DM1), the most common form of muscular dystrophy in adults, is an RNA-mediated disease. Dramatically expanded (CUG) repeats accumulate in nuclei and sequester RNA-binding proteins such as the splicing regulator MBNL1. We have employed resin-bound dynamic combinatorial chemistry (RBDCC) to identify the first examples of compounds able to inhibit MBNL1 binding to (CUG) repeat RNA. Screening an RBDCL with a theoretical diversity of 11 325 members yielded several molecules  ...[more]

Similar Datasets

Unknown Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a Drosophila model of myotonic dystrophy.
| S-EPMC5963859 | biostudies-literature
Unknown A novel CUG(exp)·MBNL1 inhibitor with therapeutic potential for myotonic dystrophy type 1.
| S-EPMC3683132 | biostudies-literature
Unknown Phenylbutazone induces expression of MBNL1 and suppresses formation of MBNL1-CUG RNA foci in a mouse model of myotonic dystrophy.
| S-EPMC4850456 | biostudies-literature
Unknown Actinomycin D Specifically Reduces Expanded CUG Repeat RNA in Myotonic Dystrophy Models.
| S-EPMC4691565 | biostudies-literature
Unknown Expanded CUG Repeat RNA Induces Premature Senescence in Myotonic Dystrophy Model Cells.
| S-EPMC8990169 | biostudies-literature
Unknown Single-molecule study of the CUG repeat-MBNL1 interaction and its inhibition by small molecules.
| S-EPMC3711446 | biostudies-literature
Unknown Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells.
| S-EPMC2996918 | biostudies-other
Unknown Dynamic docking of small molecules targeting RNA CUG repeats causing myotonic dystrophy type 1.
| S-EPMC9822796 | biostudies-literature
Transcriptomics Expanded CUG repeat RNA alters gene expression profiles in myotonic dystrophy model cells
2022-04-19 | GSE196265 | GEO
Unknown Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model.
| S-EPMC6475439 | biostudies-literature